Related references
Note: Only part of the references are listed.Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
Marion Dajon et al.
IMMUNOBIOLOGY (2017)
Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells
D-W Yeh et al.
CELL DEATH AND DIFFERENTIATION (2016)
Deubiquitinase CYLD acts as a negative regulator for bacterium NTHi-induced inflammation by suppressing K63-linked ubiquitination of MyD88
Byung-Cheol Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice
Dinesh Babu Uthaya Kumar et al.
GASTROENTEROLOGY (2016)
Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells
Chih-Cheng Hsiao et al.
CANCER LETTERS (2015)
Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma
Wen-Ting Liu et al.
CANCER LETTERS (2015)
TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase
Wei Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6
Dandan Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The demographics of the ubiquitin system
Michael J. Clague et al.
TRENDS IN CELL BIOLOGY (2015)
TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
Dayson Moreira et al.
ONCOTARGET (2015)
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
Lovisa Farnebo et al.
ONCOTARGET (2015)
USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms
Zhifen Yang et al.
SCIENTIFIC REPORTS (2015)
β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer
D. Jia et al.
CELL DEATH AND DIFFERENTIATION (2015)
Cancer stem cells: a systems biology view of their role in prognosis and therapy
Susan D. Mertins
ANTI-CANCER DRUGS (2014)
Cancer Stem-like Cells Derived from Chemoresistant Tumors Have a Unique Capacity to Prime Tumorigenic Myeloid Cells
Tsunaki Yamashina et al.
CANCER RESEARCH (2014)
TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small Cell Lung Cancer
Saradiya Chatterjee et al.
CANCER RESEARCH (2014)
Ubiquitin in the immune system
Julia Zinngrebe et al.
EMBO REPORTS (2014)
Cancer stem cells - important players in tumor therapy resistance
Selcuk Colak et al.
FEBS JOURNAL (2014)
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Soufiane Boumahdi et al.
NATURE (2014)
A cell-intrinsic role for TLR2 MYD88 in intestinal and breast epithelia and oncogenesis
Ferenc A. Scheeren et al.
NATURE CELL BIOLOGY (2014)
Ubiquitination in disease pathogenesis and treatment
Doris Popovic et al.
NATURE MEDICINE (2014)
Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients
Fang-Jing Ma et al.
PLOS ONE (2014)
Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis
Huan Yang et al.
PLOS ONE (2014)
HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling
Takashi Tanaka et al.
SCIENCE SIGNALING (2014)
Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma
Wenna Shi et al.
TUMOR BIOLOGY (2014)
Tuning NF-κB activity: A touch of COMMD proteins
Paulina Bartuzi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
Ilana Chefetz et al.
CELL CYCLE (2013)
Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment-Poor Prognosis or New Therapeutic Opportunity
Lisa A. Ridnour et al.
CLINICAL CANCER RESEARCH (2013)
USP10 inhibits genotoxic NF-κB activation by MCPIP1-facilitated deubiquitination of NEMO
Jixiao Niu et al.
EMBO JOURNAL (2013)
Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway
Jo Meagan Garner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex
Xikui Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Ubiquitin-Specific Proteases 25 Negatively Regulates Virus-Induced Type I Interferon Signaling
Huijuan Zhong et al.
PLOS ONE (2013)
USP2a negatively regulates IL-1-and virus-induced NF-B activation by deubiquitinating TRAF6
Xiao He et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav et al.
NATURE REVIEWS CANCER (2013)
Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration
Ning Xiao et al.
BIOCHEMICAL JOURNAL (2012)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
Hazel Tye et al.
CANCER CELL (2012)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
NF-κB as a Target for Modulating Inflammatory Responses
Chiara Gasparini et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Regulation of NF-κB by deubiquitinases
Edward W. Harhaj et al.
IMMUNOLOGICAL REVIEWS (2012)
NF-κB and the link between inflammation and cancer
Joseph A. DiDonato et al.
IMMUNOLOGICAL REVIEWS (2012)
Ubiquitin-specific Protease 4 Mitigates Toll-like/Interleukin-1 Receptor Signaling and Regulates Innate Immune Activation
FangFang Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
Atsuo Ochi et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma
Richa Tewari et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
Yijing Li et al.
MOLECULAR CANCER (2012)
Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25
Bo Zhong et al.
NATURE IMMUNOLOGY (2012)
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
S. M. Kumar et al.
ONCOGENE (2012)
Inflammation linking EMT and cancer stem cells
Chenchen Zhou et al.
ORAL ONCOLOGY (2012)
Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells
Lei Wang et al.
STEM CELL RESEARCH & THERAPY (2012)
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
Salome Gonzalez-Reyes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation
Y-H Fan et al.
CELL DEATH AND DIFFERENTIATION (2011)
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Hasan Korkaya et al.
CLINICAL CANCER RESEARCH (2011)
Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus
Julia Strebovsky et al.
FASEB JOURNAL (2011)
Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5
Eun-Jung Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation
H. D. Park et al.
ONCOGENE (2011)
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma
Ilyar Sheyhidin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappa B signalling
Vinagolu K. Rajasekhar et al.
NATURE COMMUNICATIONS (2011)
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
Chao Wang et al.
BMC CANCER (2010)
Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
Salome Gonzalez-Reyes et al.
BMC CANCER (2010)
Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
M. Murohashi et al.
BRITISH JOURNAL OF CANCER (2010)
The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
Manran Liu et al.
CANCER RESEARCH (2010)
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors
Regina Berger et al.
CANCER SCIENCE (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Ubiquitin-specific Peptidase 21 Inhibits Tumor Necrosis Factor α-induced Nuclear Factor κB Activation via Binding to and Deubiquitinating Receptor-interacting Protein 1
Gufeng Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TNFalpha Up-Regulates SLUG Via the NF-kappaB/HIF1alpha Axis, Which Imparts Breast Cancer Cells With a Stem Cell-Like Phenotype
Gianluca Storci et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
Julien Cherfils-Vicini et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion
Huan Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker
Rosaria Cammarota et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Toll-Like Receptors, Tissue Injury, and Tumourigenesis
Savvas Ioannou et al.
MEDIATORS OF INFLAMMATION (2010)
DAMPening Inflammation by Modulating TLR Signalling
A. M. Piccinini et al.
MEDIATORS OF INFLAMMATION (2010)
The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation
Lianyun Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
Sandrine Daubeuf et al.
BLOOD (2009)
Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack
Miroslaw J. Szczepanski et al.
CANCER RESEARCH (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
Ayesha B. Alvero et al.
CELL CYCLE (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
Kim Midwood et al.
NATURE MEDICINE (2009)
Endogenous Damage-Associated Molecular Pattern Molecules at the Crossroads of Inflammation and Cancer
Geetha Srikrishna et al.
NEOPLASIA (2009)
Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury
Yumiko Imai et al.
CELL (2008)
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma
Shih-Hwa Chiou et al.
CLINICAL CANCER RESEARCH (2008)
Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling
Annie Bibeau-Poirier et al.
CYTOKINE (2008)
The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals
Osamu Hitotsumatsu et al.
IMMUNITY (2008)
NF-kappa B Signaling Pathway and Its Therapeutic Implications in Human Diseases
Fazlul H. Sarkar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
Richard Birnie et al.
GENOME BIOLOGY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors
Masayuki Fukata et al.
GASTROENTEROLOGY (2007)
The deubiquitinating enzyme USP11 controls an IκB kinase α(IKKα)-p53 signaling pathway in response to tumor necrosis factor α(TNFα)
Tomoko Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD
Ato Wright et al.
DEVELOPMENTAL CELL (2007)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Toll-like receptors in inflammation, infection and cancer
Keqiang Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
COMMD proteins: COMMing to the scene
G. N. Maine et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit
Takashi Tanaka et al.
NATURE IMMUNOLOGY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling
Bo Huang et al.
CANCER RESEARCH (2007)
TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance
Weigang He et al.
MOLECULAR IMMUNOLOGY (2007)
CSN controls NF-κB by deubiquitinylation of IκBα
Katrin Schweitzer et al.
EMBO JOURNAL (2007)
COMMD proteins and the control of the NFκB pathway
Gabriel N. Maine et al.
CELL CYCLE (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase
Gabriel N. Maine et al.
EMBO JOURNAL (2007)
Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding
Colleen Fearns et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of hyaluronan degradation products as innate alloimmune agonists
B. M. Tesar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB
Claudio Mauro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation
A Mansell et al.
NATURE IMMUNOLOGY (2006)
TLR signaling pathways: Opportunities for activation and blockade in pursuit of therapy
K. Hoebe et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 and TRAF7
H Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
J Vollmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
DH Jiang et al.
NATURE MEDICINE (2005)
Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus
FJ Barrat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation
LB Ru et al.
ARTHRITIS AND RHEUMATISM (2005)
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages
L Schaefer et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
COMMD proteins, a novel family of structural and functional homologs of MURR1
E Burstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate, crystal-induced nitric oxide generation
R Liu-Bryan et al.
JOURNAL OF IMMUNOLOGY (2005)
mRNA is an endogenous ligand for Toll-like receptor 3
K Karikó et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
SS Diebold et al.
SCIENCE (2004)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
NF-κB is essential for induction of CYLD, the negative regulator of NF-κB -: Evidence for a novel inducible autoregulatory feedback pathway
H Jono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
IE Wertz et al.
NATURE (2004)
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
DL Boone et al.
NATURE IMMUNOLOGY (2004)
RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation
E Meylan et al.
NATURE IMMUNOLOGY (2004)
LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF
KA Fitzgerald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
E Trompouki et al.
NATURE (2003)
The Toll-IL-1 receptor adaptor family grows to five members
LAJ O'Neill et al.
TRENDS IN IMMUNOLOGY (2003)
Regulation of NF-kappa B signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA
A Ryo et al.
MOLECULAR CELL (2003)
Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2
A Biragyn et al.
SCIENCE (2002)
SOCS-1 participates in negative regulation of LPS responses
R Nakagawa et al.
IMMUNITY (2002)
Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins
O Takeuchi et al.
JOURNAL OF IMMUNOLOGY (2002)
The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the toll-like receptor 2/4 pathway
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4
GB Johnson et al.
JOURNAL OF IMMUNOLOGY (2002)
HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
EA Leadbetter et al.
NATURE (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent
P Massari et al.
JOURNAL OF IMMUNOLOGY (2002)
A T cell-specific enhancer of the human CD40 ligand gene
LA Schubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
ML Guzman et al.
BLOOD (2001)
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4
ST Smiley et al.
JOURNAL OF IMMUNOLOGY (2001)
Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
C Wang et al.
NATURE (2001)
Discrimination of bacterial lipoproteins by Toll-like receptor 6
O Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2001)
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
F Hayashi et al.
NATURE (2001)
The extra domain A of fibronectin activates toll-like receptor 4
Y Okamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells
TH Chuang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
A Ozinsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
L Deng et al.
CELL (2000)
The role of CpG motifs in innate immunity
AM Krieg
CURRENT OPINION IN IMMUNOLOGY (2000)
Share Paper
